RENAL ALLOGRAFT OUTCOMES IN LIVE DONOR RECIPIENTS ON TACROLIMUS BASED TRIPLE IMMUNOSUPPRESSION WITH AND WITHOUT BASILIXIMAB INDUCTION

被引：0
|
作者：
Sakhuja, Vinay [1 ]
Gundlapalli, Srikanth [1 ]
Rathi, Manish [1 ]
Jha, Vivekanand [1 ]
Kohli, H. S. [1 ]
Sharma, Ashish [1 ]
Minz, M. [1 ]
机构：
[1] PGIMER, Chandigarh, India
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2013年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：513 / 513
页数：1
相关论文
共 50 条
  • [41] The pathologic impact of tacrolimus on protocol biopsy in renal transplant patients with basiliximab-based immunosuppression
    Sakai, K
    Miyagi, Y
    Hasegawa, T
    Itabashi, Y
    Muramatsu, M
    Sugiyama, K
    Kawamura, T
    Arai, K
    Aikawa, A
    Ohara, T
    Mizuiri, S
    Hasegawa, A
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (04) : 1757 - 1759
  • [42] Induction immunosuppression with rabbit antithymocyte globulin or basiliximab: A single center, 3 year study in 432 deceased donor renal transplant recipients.
    Ingle, GR
    Aswad, S
    Shah, T
    Dudley, K
    Khetan, U
    Liang, L
    Naraghi, R
    Shidban, H
    Mendez, R
    Mendez, R
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 188 - 189
  • [43] Differences in Rejection and Clinical Outcomes in Obese versus Non-Obese Renal Transplant Recipients Receiving Basiliximab Induction Immunosuppression.
    Benken, J.
    Kane, C.
    Lichvar, A.
    Benedetti, E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 673 - 673
  • [44] PEDIATRIC PRIMARY LIVE-DONOR-KIDNEY TRANSPLANT-RECIPIENTS OUTCOMES BY IMMUNOSUPPRESSION INDUCTION RECEIVED IN THE UNITED STATES
    Riad, Samy
    Jackson, Scott
    Chinnakotla, Srinath
    Verghese, Priya
    TRANSPLANTATION, 2020, 104 (09) : S607 - S607
  • [45] Primary pediatric live-donor-kidney transplant-recipients' outcomes by immunosuppression induction received in the United States
    Riad, Samy
    Jackson, Scott
    Chinnakotla, Srinath
    Verghese, Priya
    PEDIATRIC TRANSPLANTATION, 2021, 25 (05)
  • [46] Lack of economic benefit with basiliximab induction in living related donor adult renal transplant recipients
    Crompton, JA
    Somerville, T
    Smith, L
    Corbett, J
    Nelson, E
    Holman, J
    Shihab, FS
    PHARMACOTHERAPY, 2003, 23 (04): : 443 - 450
  • [47] Open-Label, Randomized Study of Transition From Tacrolimus to Sirolimus Immunosuppression in Renal Allograft Recipients
    Tedesco-Silva, Helio
    Peddi, V. Ram
    Sanchez-Fructuoso, Ana
    Marder, Brad A.
    Russ, Graeme R.
    Diekmann, Fritz
    Flynn, Alison
    Hahn, Carolyn M.
    Li, Huihua
    Tortorici, Michael A.
    Schulman, Seth L.
    TRANSPLANTATION DIRECT, 2016, 2 (04):
  • [48] COMPARISON OF BASILIXIMAB VS NO INDUCTION ON 12-MONTHS RENAL FUNCTION IN KIDNEY TRANSPLANT RECIPIENTS IN THE TACROLIMUS ERA
    Lys, Zdenek
    Valkovsky, Ivo
    Havranek, Pavel
    Dedochova, Jarmila
    Polaskova, Jana
    Vaclavik, Jan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [49] The use of tacrolimus as induction and maintenance immunosuppression in renal cadaveric transplant recipients over the age of 60
    Xenos, EX
    Ciancio, G
    Burke, GW
    Roth, D
    Miller, J
    CLINICAL TRANSPLANTATION, 1997, 11 (05) : 497 - 499
  • [50] COMPARISON OF BASILIXIMAB VS NO INDUCTION ON 24-MONTHS RENAL FUNCTION IN KIDNEY TRANSPLANT RECIPIENTS IN THE TACROLIMUS ERA
    Lys, Zdenek
    Dedochova, Jarmila
    Polaskova, Jana
    Valkovsky, Ivo
    Havranek, Pavel
    Vaclavik, Jan
    TRANSPLANT INTERNATIONAL, 2021, 34 : 256 - 256
12345